NCT00837993View on ClinicalTrials.gov

Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

CompletedOBSERVATIONAL
Enrollment

241

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Ovarian Cancer
Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

M.D. Anderson Cancer Center

OTHER

NCT00837993 - Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System | Biotech Hunter | Biotech Hunter